Dissociable effects of <i>APOE</i>-ε4 and β-amyloid pathology on visual working memory.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34806027.
- Also identified by DOI 10.1038/s43587-021-00117-4 and PMC identifier 7612005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although <i>APOE</i>-ε4 carriers are at significantly higher risk of developing Alzheimer's disease than non-carriers<sup>1</sup>, controversial evidence suggests that <i>APOE</i>-ε4 might confer some advantages, explaining the survival of this gene (antagonistic pleiotropy)<sup>2,3</sup>. In a population-based cohort born in one week in 1946 (assessed aged 69-71), we assessed differential effects of <i>APOE</i>-ε4 and β-amyloid pathology (quantified using <sup>18</sup>F-Florbetapir-PET) on visual working memory (object-location binding). In 398 cognitively normal participants, <i>APOE</i>-ε4 and β-amyloid had opposing effects on object identification, predicting better and poorer recall respectively. ε4-carriers also recalled locations more precisely, with a greater advantage at higher β-amyloid burden. These results provide evidence of superior visual working memory in ε4-carriers, showing that some benefits of this genotype are demonstrable in older age, even in the preclinical stages of Alzheimer's disease.
Medical subject headings
- Alzheimer Disease